Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection
A Study to Evaluate the Effectiveness of the Rover Cervex-Brush Device vs. the Personal Pap Smear Device™ for Collection of Cervical Cells for Detecting Cervical Dysplasia or Neoplasia
1 other identifier
interventional
200
1 country
1
Brief Summary
This purpose of this research study is to determine the effectiveness of the Personal Pap Smear Device™ to collect adequate cervical cell samples for cytology examination when compared with the Rover Cervex-Brush (Cervix-Examination Brush).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2024
CompletedFirst Posted
Study publicly available on registry
January 29, 2024
CompletedStudy Start
First participant enrolled
July 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedJuly 20, 2025
July 1, 2025
1.4 years
January 10, 2024
July 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of the samples for the Predicate Device versus PPS device
Data of Adequate versus Inadequate will be reported to include a positive percent agreement (PPA) defined as PPA= A/(A+C) and the negative percent agreement (NPA) defined as NPA = D/(B+D) along with their 95% confidence bounds using the Clopper-Pearson method.
Baseline
Secondary Outcomes (1)
The Comparison of Cell Types of the PPS Device versus the Predicate Device
Baseline
Study Arms (2)
Pap smear collection using the Personal Pap Smear (PPS) Device
EXPERIMENTALThe investigational device, trade named the Personal Pap Smear™ (PPS) developed by GyneConcepts of Atlanta, Georgia. It arrives completely assembled, and ready-for-use, in a sealed plastic bag. The PPS device is a multi-component assembly designed for the collection of exfoliated cervical epithelial cells. Its four major components are the (1) Tube Body, (2) U-Ring and attached Aligning Spoon, (3) Ball Handle, (with permanently anchored bristle Collection Brush), and (4) Safety Cover.
Pap smear collection using the Rovers Cervex-Brush
ACTIVE COMPARATORThe Predicate device utilized in this study is the Cervix-Examination Brush, manufactured by Rover (Manufacturers Code: 9443). The Cervex-Brush (CervixExamination Brush) is made of polyethylene and has a total length of 20 centimeters. The top portion uses a soft flexible brush to obtain cell samples. The brush consists of 57 semi-circular plastic bristles of various lengths. The shape is such that the top edges of the brush follow the contours of the cervix. The longer middle bristles reach deep into the endocervical canal- 'Os'. The shorter bristles touch both the ectocervical area and transformation zone at the same time. This device is packaged with identical standards used for packaging commercial tampons.
Interventions
Diagnostic Test: Use of PPS device to collect cervical cells during pap smear collection.
Diagnostic Test: Use of Rovers Cervex-Brush to collect cervical cells during pap smear collection.
Eligibility Criteria
You may qualify if:
- Adult women, aged 21-65 years old.
- Do not have any medical or psychiatric condition affecting the ability to give voluntary informed consent.
- Be able to read and understand English
You may not qualify if:
- Participants currently on menses
- Inability to provide Informed Consent
- Previous total hysterectomy
- History of radiation treatment for cervical cancer
- Pregnancy
- Medical condition that interferes with conduct of study, in investigator's opinion
- Evidence of active cervical infection requiring treatment
- Known bleeding diathesis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Morehouse School of Medicinelead
- GyneConcepts, Inc.collaborator
Study Sites (1)
Morehouse School of Medicine
Atlanta, Georgia, 30310, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Regina K Leonis, MD, MD
Morehouse School of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 10, 2024
First Posted
January 29, 2024
Study Start
July 25, 2024
Primary Completion
December 31, 2025
Study Completion
March 30, 2026
Last Updated
July 20, 2025
Record last verified: 2025-07